Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Neurofusion is a Korean financial AI platform company positioned as a next-generation financial AI platform that combines finance, AI, and cognitive science. Its current core product is Valley AI, which offers investors Bloomberg-level data accessibility, an intuitive UX, investment education, and community competitions. Its goal is to make financial information capabilities that were previously dominated by institutions available to individual investors.
Valley AI covers stock screening, financial statement analysis, valuation, macro analysis, and portfolio analysis across the investment workflow. The source text says it provides 38 professional features. On the AI side, Neurofusion emphasizes a NeuroSymbolic methodology and plans to launch CereFin AI, a finance-specific reasoning engine, in 2026. Through its own protocol, CereFin AI is intended to connect financial data sources, platform features, and AI models, using ontologies and knowledge graphs to analyze causal relationships between financial events rather than just correlations. Its 2027 direction, Epsilon AI, is more research-oriented and plans to use devices such as EEG, rPPG, and smartwatches to monitor investor emotions and cognitive biases.
The collected text does not disclose subscription pricing, free tiers, trial policies, or payment methods, making it difficult to assess value for money. The page mentions that the platform already has subscribers and includes a “Start using Valley AI” call-to-action, but it does not specify registration requirements, regional availability, or enterprise-level capabilities.
Its strengths lie in its focus on finance-specific use cases rather than simply wrapping a general-purpose LLM. Its features cover the full investment research workflow, and by combining Wall Street expert courses, company/macro analysis competitions, and community features, it can create a closed loop of learning, analysis, and practice. Licensed Dow Jones News content, premium news from sources such as WSJ, and real-time breaking news are also major advantages.
The limitations are also clear: CereFin AI and Epsilon AI are marked for 2026 and 2027 respectively, suggesting that the key AI reasoning and cognitive-science capabilities are still in the planning or research stage. The page also does not provide information on model accuracy, data coverage, backtesting results, privacy compliance, API access, or Chinese-language support.
It is better suited to individual investors or advanced learners who want to systematically study value investing, macro analysis, and portfolio management, while also needing an integrated financial analysis tool. Access from China is unclear. The page is mainly in Korean, and there is no visible indication of Chinese-language support, RMB payments, or China-local market data. For alternatives in the Chinese market, consider Wind, 同花顺 iFinD, and Choice. International alternatives include Bloomberg Terminal, Koyfin, TIKR, TradingView, and Seeking Alpha.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on neurofusion.ai official site.
neurofusion.ai is an South Korea Finance provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach neurofusion.ai directly.